Healthtech Startups
16,921 companies tagged Healthtech, with their investors and founders.
Oncimmune is a biomarker discovery and diagnostics company specializing in proteomics and bioinformatics technologies for autoimmunity, cancer research, and clinical drug development. The company serves pharmaceutical, biotech, and academic partners by developing diagnostic tools and biomarkers for various phases of clinical development.
2 investors
Onco provides cancer patients in India with access to expert oncologists, quality treatment centers, discounted cancer medicines, diagnostic tests, and support throughout their treatment journey. The platform connects patients with specialists, offers curated treatment packages, and provides survivor mentorship and remote answers to cancer-related queries.
2 investors
Oncoinvent is a biotechnology company focused on drug development and commercialization in the pharmaceutical sector. The company is led by executives with extensive experience in biotech management, clinical programs, and global pharmaceutical commercialization.
2 investors
OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders. It advances its pipeline through internal R&D and external partnerships, including a collaboration with BioNTech to develop and commercialize gotistobart.
2 investors
Mereo BioPharma is a rare disease drug developer that funds and advances novel therapeutic candidates not progressed by their originating pharmaceutical or biotech companies, with lead programs in osteogenesis imperfecta and Alpha-1 Antitrypsin Deficiency-associated Lung Disease. It operates a capital-efficient model, retaining regional development rights while forming strategic partnerships, and collaborates with patient communities in the rare disease space.
2 investors
Oncorena is a Swedish pharmaceutical company developing a breakthrough treatment for metastatic renal cancer based on the drug candidate ONC175 (orellanine). The company targets an orphan drug indication with clinical development underway.
2 investors
OncoRes Medical develops an intraoperative imaging technology that combines optical coherence tomography (OCT) and elastography to give surgeons real-time assessment of tissue microstructure at a resolution comparable to histology. The medical device company works with breast cancer surgeons and pathologists and is developing its technology for surgical use.
2 investors
One Step Software provides workflow automation tools for behavioral health and recovery organizations, including treatment centers, sober living facilities, and drug courts. The platform consolidates program management operations into a single system to streamline client coordination and data tracking.
2 investors
Onederful provides an API that gives dental practice software platforms real-time access to patient insurance eligibility and benefits information, enabling coverage verification, treatment plan estimates, and reduced claim rejections. Now part of Vyne Dental, the product connects dental offices to payers and pairs with Vyne Trellis, a dental revenue cycle management and billing platform.
2 investors
OneStep uses smartphone-based AI to perform clinical-grade gait analysis and motion detection for healthcare providers. The platform helps identify fall risk, track recovery, and monitor mobility-related conditions across chronic pain, neurological, cardiac, and post-surgical care.
2 investors
OneVillage is a personalized health platform that offers employers and their employees customized coaching, benefits management, and health programs. The platform connects individuals with personalized guidance and resources to improve well-being.
2 investors
OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3KΞ± pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies. Its focus is on selective, allosteric small-molecule oncology therapeutics.
2 investors
ONWARD Health Research is a technology and services company offering tech-enabled clinical trials through its ONWARDAccess platform, which is customized to match clinical trial protocols. It serves the pharma/biotech, medical device, and digital health sectors, with a focus on the Asia-Pacific region.
2 investors
OODA Health builds patient billing and claims-payment technology that coordinates payers, providers, and patients to handle healthcare payments at the point of care. The company works with U.S. health plans and provider systems and has entered an agreement to be acquired by Cedar.
2 investors
Opal HTM develops software and IoT sensor systems to track and optimize hospital medical equipment utilization, maintenance, and inventory management. The platform serves healthcare facilities by combining real-time equipment monitoring with predictive maintenance analytics to reduce costs and improve patient care.
2 investors
Opalite builds language interpretation technology for healthcare, enabling real-time communication between physicians and patients across language barriers. The platform serves clinicians and care teams to improve patient safety and diagnostic accuracy.
2 investors
operasan is a German company that operates nephrology and dialysis centers, providing outpatient treatment for patients with kidney disease across 30 locations. It offers nephrologists a network to integrate their practices, cooperating with care providers and payers.
2 investors
Ophidion is an early-stage CNS biopharmaceutical company developing a non-invasive carrier technology that delivers gene-silencing agents and other therapeutics across the blood-brain barrier into the brain. It is building a pipeline of disease-modifying and symptomatic treatments for neurodegenerative diseases, including Huntington's disease and cognition-related conditions.
2 investors
Opmed offers an AI-powered scheduling system for hospital cath labs (cardiac catheterization labs) that integrates emergency and unscheduled cases, forecasts procedure times, and coordinates specialized equipment and interdisciplinary staff. The system also provides analytics on performance and resource utilization to optimize operations over time.
2 investors
OptiMedica develops ophthalmology equipment for cataract surgery, including phacoemulsification and laser-assisted cataract surgery systems along with intraocular lenses and implants. Its products serve eye surgeons performing cataract procedures.
2 investors
Optimeos develops a nanoparticle-based drug formulation and delivery platform (CINCs and LINCs) for complex biologics including mRNA, DNA, peptides, and proteins, targeting rare diseases, immunology, and metabolic conditions such as obesity. Its technology enables intracellular and long-acting delivery for pharmaceutical and biotech partners addressing challenges like tissue targeting and dosing profiles.
2 investors
Optos develops ultra-widefield retinal imaging devices for eyecare professionals to detect, diagnose, document, and treat ocular pathology. The company's devices capture over 80% of the retina in a single image, serving ophthalmologists, optometrists, and other eye care practitioners.
2 investors
Optura helps enterprise healthcare organizations identify and implement AI initiatives with measurable returns on investment. The company provides a platform and methodology for aligning executives, evaluating AI pilots, deploying technology interventions, and tracking performance across healthcare workflows and systems.
2 investors
OPUM is a MedTech company developing medical device technologies, supported by software and hardware engineering teams. The page names its board, executive leadership, and technical team but gives limited detail on the specific product.
2 investors